The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...

Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...

Some cases expand on earlier initiatives, like the Valsartan cases. The theory against these was launched from the Zantac ...

The FDA announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter decongestants – from the market, citing evidence that it doesn't work.

With Donald Trump all set to become US president, Indian exporters may face high customs duties for goods like automobiles, textiles and pharmaceuticals if the new US administration decides to pursue ...

GSK shares fell on Wednesday after the group's vaccine sales continued to disappoint in the third quarter. The drugmaker saw weaker-than-expected demand for its respiratory syncytial virus (RSV ...

The UK’s second-biggest pharmaceutical firm still saw 2% sales growth across the business after ... of thousands of lawsuits in the US over its discontinued heartburn drug Zantac earlier in October.

GSK did reiterate its financial guidance for the year, however, helped by demand for its cancer and HIV drugs: at constant exchange rates it's still expecting revenue growth of 7% to 9% ...

Notably, GSK’s previously sold antacid Zantac may have caused cancer in some patients. Naturally, this creates some legal risks for shareholders. So far, GSK has incurred a $2.2 billion charge ...

Indie game developer Lavabird and publisher First Break Labs have continued to keep the free Steam Next Fest demo for Warside up, as we now know the game's release date. During the event, the team ...

But you’re still getting an 8.3” 60Hz IPS LCD, even though this chip ran the 120Hz display on the iPhone 15 Pro just fine. Apple Intelligence is available on devices with Apple A Pro chipsets ...

A drug under the name of Zantac 360, which does not contain the alleged cancer-causing ingredient ranitidine, is still being sold currently. GSK’s collaboration with Cambridge University comes after ...